基本信息
浏览量:240
职业迁徙
个人简介
He coordinates a prospective outcome research project and several clinical trials investigating new therapeutic strategies (including target therapies and immunotherapies) in melanoma and gastrointestinal cancer patients.
He was recently appointed Coordinator of the Mucosal and Ocular Melanoma Section of the Italian Rare Cancers Network.
Since 2011, he chaired the scientific and organizing committees of the Clinical and Translational Research Working Group of the Italian Melanoma Intergroup (IMI).
Since 2017 Dr Mandalà is secretary of IMI.
Dr Mandalà has been recently appointed chairman of the systemic treatment of the EORTC melanoma group.
He is full member of the European Society of Medical Oncology. He is Reviewer for several scientific journals, including Lancet Oncology, Cancer, British Journal of Cancer, European journal of cancer, Annals of Oncology, Cancer Treatment Review, Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, Arteriosclerosis-Thrombosis and Vascular Biology, Critical Reviews in Oncology and Haematology. He has authored more than 120 publications and his major scientific interests are clinical and translational research on melanoma, gastrointestinal cancer and thromboembolic complications in cancer patients. Since 2008, he gave major contributions in ESMO, AIOM and ISTH clinical practice guidelines on the management of venous thromboembolism and solid tumours.
He was recently appointed Coordinator of the Mucosal and Ocular Melanoma Section of the Italian Rare Cancers Network.
Since 2011, he chaired the scientific and organizing committees of the Clinical and Translational Research Working Group of the Italian Melanoma Intergroup (IMI).
Since 2017 Dr Mandalà is secretary of IMI.
Dr Mandalà has been recently appointed chairman of the systemic treatment of the EORTC melanoma group.
He is full member of the European Society of Medical Oncology. He is Reviewer for several scientific journals, including Lancet Oncology, Cancer, British Journal of Cancer, European journal of cancer, Annals of Oncology, Cancer Treatment Review, Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, Arteriosclerosis-Thrombosis and Vascular Biology, Critical Reviews in Oncology and Haematology. He has authored more than 120 publications and his major scientific interests are clinical and translational research on melanoma, gastrointestinal cancer and thromboembolic complications in cancer patients. Since 2008, he gave major contributions in ESMO, AIOM and ISTH clinical practice guidelines on the management of venous thromboembolism and solid tumours.
研究兴趣
论文共 264 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Zenodo (CERN European Organization for Nuclear Research)no. 1 (2024): 1-12
引用0浏览0WOS引用
0
0
JOURNAL OF CLINICAL ONCOLOGYno. 29 (2023): 4621-+
Cancerno. 15 (2023): 2331-2340
Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
引用1浏览0WOS引用
1
0
European journal of cancer (Oxford, England : 1990) (2023)
引用1浏览0WOS引用
1
0
Clinical cancer research : an official journal of the American Association for Cancer Researchno. 17 (2023): 3352-3361
Future Oncologyno. 16 (2023): 1091-1098
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn